Gene · 4057
Papers3,179
Newest first. Swiss-Prot's references are curated; PubTator's text mining finds papers that name the gene, not always ones about it.
861 to 880 of 3,179
Download this page as JSON| Title | Journal | Year | PMID | Found by | Source |
|---|---|---|---|---|---|
| The Origins of NAFLD: The Potential Implication of Intrauterine Life and Early Postnatal Period. | Cells | 2022 | 35159371 | PubTator, text mining | PubMed |
| Legume Lectins with Different Specificities as Potential Glycan Probes for Pathogenic Enveloped Viruses. | Cells | 2022 | 35159151 | PubTator, text mining | PubMed |
| Investigating changes of proteome in the bovine milk serum after retort processing using proteomics techniques. | Food Sci Nutr | 2022 | 35154669 | PubTator, text mining | PubMed |
| Temporal analyses of postnatal liver development and maturation by single-cell transcriptomics. | Dev Cell | 2022 | 35134346 | PubTator, text mining | PubMed |
| RNA sequencing on muscle biopsy from a 5-week bed rest study reveals the effect of exercise and potential interactions with dorsal root ganglion neurons. | Physiol Rep | 2022 | 35133080 | PubTator, text mining | PubMed |
| Reduction of lactoferrin aggravates neuronal ferroptosis after intracerebral hemorrhagic stroke in hyperglycemic mice. | Redox Biol | 2022 | 35131600 | PubTator, text mining | PubMed |
| Subtyping of Human Papillomavirus-Positive Cervical Cancers Based on the Expression Profiles of 50 Genes. | Front Immunol | 2022 | 35126391 | PubTator, text mining | PubMed |
| Quantitative proteomic analysis of GnRH agonist treated GBM cell line LN229 revealed regulatory proteins inhibiting cancer cell proliferation. | BMC Cancer | 2022 | 35109816 | PubTator, text mining | PubMed |
| Identification of LTF as a Prognostic Biomarker for Osteosarcoma. | J Oncol | 2022 | 35096061 | PubTator, text mining | PubMed |
| Identification of a novel HOOK3-FGFR1 fusion gene involved in activation of the NF-kappaB pathway. | Cancer Cell Int | 2022 | 35081975 | PubTator, text mining | PubMed |
| Prognostic implications of N6-methyladenosine RNA regulators in breast cancer. | Sci Rep | 2022 | 35075167 | PubTator, text mining | PubMed |
| Plasmalemmal V-ATPase as a Potential Biomarker for Lactoferrin-Based Anticancer Therapy. | Biomolecules | 2022 | 35053267 | PubTator, text mining | PubMed |
| Different Metabolomic and Proteomic Profiles of Cerebrospinal Fluid in Ventricular and Lumbar Compartments in Relation to Leptomeningeal Metastases. | Metabolites | 2022 | 35050202 | PubTator, text mining | PubMed |
| Hypoxia Increases the Potential for Neutrophil-mediated Endothelial Damage in Chronic Obstructive Pulmonary Disease. | Am J Respir Crit Care Med | 2022 | 35044899 | PubTator, text mining | PubMed |
| Mammals' humoral immune proteins and peptides targeting the bacterial envelope: from natural protection to therapeutic applications against multidrug-resistant Gram-negatives. | Biol Rev Camb Philos Soc | 2022 | 35043558 | PubTator, text mining | PubMed |
| The association of obesity with thyroid carcinoma risk. | Cancer Med | 2022 | 35032114 | PubTator, text mining | PubMed |
| Comparative secretome analysis of Staphylococcus aureus strains with different within-herd intramammary infection prevalence. | Virulence | 2022 | 35030987 | PubTator, text mining | PubMed |
| Proteomic Investigation in Plasma from Women with Fibromyalgia in Response to a 15-wk Resistance Exercise Intervention. | Med Sci Sports Exerc | 2022 | 35029590 | PubTator, text mining | PubMed |
| Low Density Granulocytes and Dysregulated Neutrophils Driving Autoinflammatory Manifestations in NEMO Deficiency. | J Clin Immunol | 2022 | 35028801 | PubTator, text mining | PubMed |
| The Potential Mechanisms by which Artemisinin and Its Derivatives Induce Ferroptosis in the Treatment of Cancer. | Oxid Med Cell Longev | 2022 | 35028002 | PubTator, text mining | PubMed |
gene-search-2026-11-11-0.2.0
Sources 12
- ClinicalTrials.gov's posted results, through CTTI's AACTFreely available. Acknowledgement requested
- ChEMBL, through Open TargetsCC BY-SA 3.0
- ClinicalTrials.govNo license stated
- EMBL-EBI's patent proteinsNo added restrictions. Attribution expected
- GenBank's patent filesNo restrictions from NCBI. Submitters may hold rights
- HGNCCC0
- NCBI GenePublic domain (US government)
- NIH's project files and grant-paper linksPublic domain
- Open TargetsCC0 1.0
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0
Each source's terms
- ClinicalTrials.gov's posted results, through CTTI's AACTClinicalTrials.gov data via Aggregate Analysis of ClinicalTrials.gov (AACT), CTTI. CTTI makes its materials freely available and requests acknowledgement. https://aact.ctti-clinicaltrials.org/documentation/299
- ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- ClinicalTrials.govnone stated
- EMBL-EBI's patent proteinsEMBL-EBI's patent protein files from the EPO, JPO, KIPO and USPTO. EMBL-EBI: "EMBL-EBI itself places no additional restrictions on the use or redistribution of the data available via its Data Resources and Tools other than those provided by the original data owners" and "EMBL-EBI expects attribution (e.g. in publications, services or products) for the use of any of its Data Resources and Tools." Read on 11 Nov 2026 at https://www.ebi.ac.uk/about/terms-of-use
- GenBank's patent filesGenBank's patent files. NCBI: "NCBI places no restrictions on the use or distribution of the GenBank data. However, some submitters may claim patent, copyright, or other intellectual property rights in all or a portion of the data they have submitted." Read on 11 Nov 2026 at https://www.ncbi.nlm.nih.gov/genbank/about/
- HGNCCC0: https://www.genenames.org/about/license/
- NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- NIH's project files and grant-paper linksPublic domain (NIH RePORTER)
- Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this list from software.
Twenty rows a page, as JSON. No key.
GET https://conductscience.org/api/genes/v1/4057/papers?page=44